FDA Panel Urges Approval of Hepatitis C Drug
In an 18-0 vote, an FDA advisory panel recommended approval of the drug boceprevir to treat hepatitis C.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
